Cart
sales@molnova.com
Butylboronicacid
CAS No. 4426-47-5
Butylboronicacid( —— )
Catalog No. M36861 CAS No. 4426-47-5
Butylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 27 | In Stock |
|
| 1G | 36 | In Stock |
|
Biological Information
-
Product NameButylboronicacid
-
NoteResearch use only, not for human use.
-
Brief DescriptionButylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
-
DescriptionButylboronicacid is a competitive inhibitor of urease and acts as a monosaccharide complexing reagent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4426-47-5
-
Formula Weight101.94
-
Molecular FormulaC4H11BO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCB(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Minimolide F
Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
-
Porcine dynorphin A(...
Porcine dynorphin A (1-13) is a potent, endogenous κ opioid receptor agonist and is antinociceptive at physiological concentrations. Exposure to dynorphin A (1-13) causes acute increases in [Ca2+]i in individual neurons similar to increases seen with acute NMDA treatment.
-
lorvotuzumab
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.
